Omalizumabe no tratamento de urticária solar refratária aos anti-histamínicos: relato de caso e revisão da literatura

Aquino, Bárbara Martins de; Lacerda, Alex Eustáquio de; Nunes, Inês Cristina Camelo; Ensina, Luis Felipe Chiaverini.
Arq. Asma, Alerg. Imunol ; 5(3): 306-311, jul.set.2021. ilus
Artículo en Portugués | LILACS | ID: biblio-1399405

Documentos relacionados

  1. Do regional geography and race influence management of chronic spontaneous urticaria?
  2. Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020.
  3. Elevated baseline soluble FcεRI may be linked to early response to omalizumab treatment in chronic spontaneous urticaria.
  4. Chronic spontaneous urticaria guidelines: What is new?
  5. Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria.
  6. New treatments for chronic urticaria.
  7. Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension study.
  8. Total IgE as a biomarker of omalizumab response in chronic spontaneous urticaria: A meta-analysis.
  9. Chronic Urticaria. Reply.
  10. Concise update on the pathogenesis of chronic spontaneous urticaria (CSU).